Drug Trial Radar · NCT07398417
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
620
Planned (sponsor's estimate)
Start
Jan 14, 2026
Primary completion
Mar 2028
Study completion Mar 2028
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.
Conditions
- Fibromyalgia
Interventions
AXS-14 (Esreboxetine)Drug
AXS-14 tablets taken once daily
PlaceboDrug
Placebo tablets taken once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time from randomization to loss of therapeutic responseTime frame: 12 Weeks
Locations
57 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Glendale, Arizona · Recruiting
Clinical Research Site
Phoenix, Arizona · Recruiting
Clinical Research Site
Tucson, Arizona · Recruiting
Clinical Research Site
Little Rock, Arkansas · Recruiting
Clinical Research Site
Anaheim, California · Recruiting
Clinical Research Site
Oceanside, California · Recruiting
Clinical Research Site
Redlands, California · Recruiting
Clinical Research Site
Sacramento, California · Recruiting
Clinical Research Site
Santa Ana, California · Recruiting
Clinical Research Site
Cromwell, Connecticut · Recruiting
Clinical Research Site
Hollywood, Florida · Recruiting
Clinical Research Site
Jacksonville, Florida · Recruiting
Clinical Research Site
Lakeland, Florida · Recruiting
Clinical Research Site
Maitland, Florida · Recruiting
Clinical Research Site
Orlando, Florida · Recruiting
Clinical Research Site
Orlando, Florida · Recruiting
Clinical Research Site
Tampa, Florida · Recruiting
Clinical Research Site
The Villages, Florida · Recruiting
Clinical Research Site
Atlanta, Georgia · Recruiting
Clinical Research Site
Atlanta, Georgia · Recruiting
Clinical Research Site
Marietta, Georgia · Recruiting
Clinical Research Site
Norcross, Georgia · Recruiting
Clinical Research Site
Chicago, Illinois · Recruiting
Clinical Research Site
Tinley Park, Illinois · Recruiting
Clinical Research Site
Kansas City, Kansas · Recruiting
Clinical Research Site
Overland Park, Kansas · Recruiting
Clinical Research Site
Overland Park, Kansas · Recruiting
Clinical Research Site
Louisville, Kentucky · Recruiting
Clinical Research Site
Prairieville, Louisiana · Recruiting
Clinical Research Site
Rockville, Maryland · Recruiting
Clinical Research Site
Boston, Massachusetts · Recruiting
Clinical Research Site
North Dartmouth, Massachusetts · Recruiting
Clinical Research Site
Watertown, Massachusetts · Recruiting
Clinical Research Site
Hazelwood, Missouri · Recruiting
Clinical Research Site
Springfield, Missouri · Recruiting
Clinical Research Site
Town and Country, Missouri · Recruiting
Clinical Research Site
Las Vegas, Nevada · Recruiting
Clinical Research Site
Brooklyn, New York · Recruiting
Clinical Research Site
Hartsdale, New York · Recruiting
Clinical Research Site
Williamsville, New York · Recruiting
Showing 40 of 57 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.